Publikationen, an denen er mitarbeitet Mario Delgado Mora (25)

2022

  1. Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic- and cholestatic-induced liver injury

    British Journal of Pharmacology, Vol. 179, Núm. 10, pp. 2275-2296

  2. Efficacy of Vafidemstat in Experimental Autoimmune Encepha-Lomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

    Pharmaceutics, Vol. 14, Núm. 7

  3. Neuropeptide Cortistatin Regulates Dermal and Pulmonary Fibrosis in an Experimental Model of Systemic Sclerosis

    Neuroendocrinology, Vol. 112, Núm. 8, pp. 784-795

2021

  1. Protective role of cortistatin in pulmonary inflammation and fibrosis

    British Journal of Pharmacology, Vol. 178, Núm. 21, pp. 4368-4388

  2. The neuropeptide cortistatin alleviates neuropathic pain in experimental models of peripheral nerve injury

    Pharmaceutics, Vol. 13, Núm. 7

2018

  1. Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses

    Journal of Immunology, Vol. 200, Núm. 11, pp. 3697-3710

2017

  1. Allogeneic adipose-derived mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by regulating self-reactive T cell responses and dendritic cell function

    Stem Cells International, Vol. 2017

  2. Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells

    Scientific Reports, Vol. 7

  3. Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction

    Histology and Histopathology, Vol. 32, Núm. 6, pp. 627-637

  4. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses

    British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 267-280

  5. Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

    Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290

2015

  1. Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

    BioMed Research International, Vol. 2015

2014

  1. Peripheral nerve reconstruction with epsilon-caprolactone conduits seeded with vasoactive intestinal peptide gene-transfected mesenchymal stem cells in a rat model

    Journal of Neural Engineering, Vol. 11, Núm. 4

  2. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders

    Arthritis and Rheumatology, Vol. 66, Núm. 2, pp. 327-339

  3. Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens

    Journal of Biological Chemistry, Vol. 289, Núm. 21, pp. 14583-14599

2013

  1. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

    Gut, Vol. 62, Núm. 8, pp. 1131-1141

  2. Analgesic effect of the neuropeptide cortistatin in murine models of arthritic inflammatory pain

    Arthritis and Rheumatism, Vol. 65, Núm. 5, pp. 1390-1401

  3. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation

    Circulation Research, Vol. 112, Núm. 11, pp. 1444-1455

2010

  1. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 241-248

2008

  1. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019